Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Monoclonal antibody against canine fibroblast activation protein that cross-reacts with mouse and human fibroblast activation protein (FAP)

Monoclonal antibody against canine fibroblast activation protein that cross-reacts with mouse and human fibroblast activation protein (FAP)

US Patent 12139550 · Granted Nov 12, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Disrupting tumor tissues by targeting fibroblast activation protein (FAP)2024
Disrupting tumor tissues by targeting fibroblast activation protein (FAP)2024
Methods for treating heart disease via redirected T cell immunotherapies2023
Compositions and methods for targeting stromal cells for the treatment of cancer2023
Compositions and methods for targeting stromal cells for the treatment of cancer2019
Compositions and methods for targeting stromal cells for the treatment of cancer2016